Answers are grounded in this paper and cite their sources.
In spite of the high social and economic cost of osteoporosis, a substantial treatment gap and projected increase of the economic burden driven by the aging populations, the use of pharmacological interventions to prevent fractures has decreased in recent years, suggesting that a change in healthcare policy is warranted.
No takes yet. Share an insight, caveat, or question.
Hernlund et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: